Nooruddin Shaik. “A Critical Review of Cinqair (Reslizumab) in the Treatment of Severe Asthma Patients”. Future Journal of Pharmaceuticals and Health Sciences 3, no. 2 (May 3, 2023): 126–133. Accessed November 16, 2024. https://pharmasprings.com/fjphs/article/view/442.